Jiang_2023_Biomed.Pharmacother_169_115874

Reference

Title : The GPIHBP1-LPL complex and its role in plasma triglyceride metabolism: Insights into chylomicronemia - Jiang_2023_Biomed.Pharmacother_169_115874
Author(s) : Jiang S , Ren Z , Yang Y , Liu Q , Zhou S , Xiao Y
Ref : Biomed Pharmacother , 169 :115874 , 2023
Abstract :

GPIHBP1 is a protein found in the endothelial cells of capillaries that is anchored by glycosylphosphatidylinositol and binds to high-density lipoproteins. GPIHBP1 attaches to lipoprotein lipase (LPL), subsequently carrying the enzyme and anchoring it to the capillary lumen. Enabling lipid metabolism is essential for the marginalization of lipoproteins alongside capillaries. Studies underscore the significance of GPIHBP1 in transporting, stabilizing, and aiding in the marginalization of LPL. The intricate interplay between GPIHBP1 and LPL has provided novel insights into chylomicronemia in recent years. Mutations hindering the formation or reducing the efficiency of the GPIHBP1-LPL complex are central to the onset of chylomicronemia. This review delves into the structural nuances of the GPIHBP1-LPL interaction, the consequences of mutations in the complex leading to chylomicronemia, and cutting-edge advancements in chylomicronemia treatment.

PubMedSearch : Jiang_2023_Biomed.Pharmacother_169_115874
PubMedID: 37951027

Related information

Citations formats

Jiang S, Ren Z, Yang Y, Liu Q, Zhou S, Xiao Y (2023)
The GPIHBP1-LPL complex and its role in plasma triglyceride metabolism: Insights into chylomicronemia
Biomed Pharmacother 169 :115874

Jiang S, Ren Z, Yang Y, Liu Q, Zhou S, Xiao Y (2023)
Biomed Pharmacother 169 :115874